• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Scientific collaboration and management of the Cooperative Agreement with WHO (World Health Organization)

Description: The cooperative agreement remains a successful scientific public health collaboration between FDA and WHO, in furthering vaccine safety through global pharmacovigilance capacity building. Year 2 funding supports development of a network of sentinel sites for vaccine signal detection, and a pharmacovigilance training course in coordination with the Uppsala Monitoring Centre in Sweden. Public health outcome: These activities support the public health goal of enhancing access of the global population to safe and effective vaccines.

Briefing Status: ON TRACK

Prior Briefing Status: ON TRACK

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

A. First quarterly progress report meeting with WHO (Year 2)

12/31/2013

Completed 11/20/2013

B. Second quarterly progress report meeting with WHO (Year 2)

3/31/2014

Completed 2/25/2014

C. Third quarterly progress report meeting with WHO (Year 2)

6/30/2014

On Track

D. Fourth quarterly progress report meeting with WHO (Year 2)

10/15/2014

Not Yet Started

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.